Phase III/Seroquel SR Bipolar Depression Monotherapy - US

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

June 30, 2007

Conditions
Affective Psychosis, BipolarDepression, BipolarManic-Depressive PsychosisPsychoses, Manic-Depressive
Interventions
DRUG

Quetiapine fumarate (Seroquel) SR

Trial Locations (54)

Unknown

Research Site, Birmingham

Research Site, Phoenix

Research Site, Scottsdale

Research Site, Little Rock

Research Site, Cerritos

Research Site, La Mesa

Research Site, Los Angeles

Research Site, Newport Beach

Research Site, Northridge

Research Site, Oceanside

Research Site, Pico Rivera

Research Site, San Diego

Research Site, Wildomar

Research Site, Washington D.C.

Research Site, Bradenton

Research Site, Fort Lauderdale

Research Site, Jacksonville

Research Site, Leesburg

Research Site, Maitland

Research Site, North Miami

Research Site, Orlando

Research Site, Tampa

Research Site, West Palm Beach

Research Site, Smyrna

Research Site, Honolulu

Research Site, Joliet

Research Site, Greenwood

Research Site, Indianapolis

Research Site, Wichita

Research Site, Shreveport

Research Site, Rockville

Research Site, Farmington Hills

Research Site, St Louis

Research Site, Cherry Hill

Research Site, Clementon

Research Site, Brooklyn

Research Site, New York

Research Site, Staten Island

Research Site, Beachwood

Research Site, Cincinnati

Research Site, Dayton

Research Site, Oklahoma City

Research Site, Portland

Research Site, Salem

Research Site, Philadelphia

Research Site, Charleston

Research Site, Memphis

Research Site, Dallas

Research Site, Houston

Research Site, Charlottesville

Research Site, Virginia Beach

Research Site, Bellevue

Research Site, Seattle

Research Site, South Kirkland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY